Who owns LEXARIA BIOSCIENCE?
- Ticker: LEXX
- CUSIP Number: 52886n406
Tip: Access positions for across all investors
Analyze quarterly positions in Lexaria Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lexaria Bioscience stock
Who bought or sold LEXARIA BIOSCIENCE this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Invenomic Capital Management | 346k | $194k | -22% | Jun 2026 |
|
| Vanguard Capital Management | 298k | $167k | 34% | Jun 2026 |
|
| Geode Capital Management | 250k | $140k | -15% | Jun 2026 |
|
| Citadel Advisors | 157k | $88k | 1061% | Jun 2026 |
|
| Toronto-Dominion Bank | 100k | $592k | -29% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 94k | $53k | 0% | Jun 2026 |
|
| Hrt Financial | 65k | $36k | 252% | Jun 2026 |
|
| UBS Group | 47k | $26k | -11% | Jun 2026 |
|
| Northern Trust | 40k | $22k | 117% | Jun 2026 |
|
| State Street Corporation | 39k | $31k | 0% | Mar 2026 |
|
| BlackRock | 27k | $15k | 0% | Jun 2026 |
|
| Intl Fcstone | 26k | $16k | 100% | Jun 2026 |
|
| Krilogy Financial | 24k | $14k | 23% | Jun 2026 |
|
| XTX Topco | 22k | $13k | -11% | Jun 2026 |
|
| Virtu Financial | 19k | $11k | 100% | Jun 2026 |
|
| Renaissance Technologies | 17k | $9.2k | 1% | Jun 2026 |
|
| Susquehanna International | 15k | $8.5k | 100% | Jun 2026 |
|
| Vontobel Holding | 15k | $8.5k | -34% | Jun 2026 |
|
| Bank Of Montreal | 14k | $11k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 10k | $5.7k | 0% | Jun 2026 |
|
| Royal Bank of Canada | 7.2k | $4.0k | 0% | Jun 2026 |
|
| Crews Bank & Trust | 3.9k | $2.2k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 2.2k | $1.2k | 263% | Jun 2026 |
|
| Citigroup | 489.00 | $380.979900 | 100% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 382.00 | $213.996400 | 0% | Jun 2026 |
|
| FMR | 213.00 | $119.003100 | 100% | Jun 2026 |
|
| Farther Finance Advisors | 172.00 | $95.993200 | 4% | Jun 2026 |
|
| Tower Research Capital | 152.00 | $84.998400 | 7500% | Jun 2026 |
|
| Barclays | 92.00 | $51.998400 | 100% | Jun 2026 |
|
| Gables Capital Management | 13.00 | $7.000500 | 0% | Jun 2026 |
|
| Morgan Stanley | 3.00 | $2.000100 | 0% | Mar 2026 |
|
| SBI Securities | 1.00 | $1.000000 | 0% | Jun 2026 |
|
Who sold out of Lexaria Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BCV Asset Management | Mar 2026 | 10k | $7.8k |
| Byrne Asset Management | Mar 2026 | 800.00 | $624.000000 |